Immunitybio
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $1,047 | $40 | $139 | $82 |
Gross Profit | -3,359 | -4,515 | -4,425 | -4,503 |
EBITDA | -99,333 | -90,641 | -79,939 | -80,136 |
EBIT | -103,739 | -95,196 | -84,503 | -84,721 |
Net Income | -134,564 | -134,109 | -233,392 | -95,582 |
Net Change In Cash | 1,047 | 40 | 139 | 82 |
Free Cash Flow | -101,071 | -108,243 | -123,226 | -93,078 |
Cash | 130,104 | 133,035 | 265,452 | 177,963 |
Basic Shares | 686,938 | 672,831 | 670,867 | 498,375 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $622 | $240 | $934 | $605 |
Gross Profit | -17,890 | -23,952 | 934 | -8,542 |
EBITDA | -342,852 | -343,978 | -316,304 | -195,128 |
EBIT | -361,364 | -368,170 | -335,426 | -204,275 |
Net Income | -583,196 | -417,320 | -349,848 | -224,187 |
Net Change In Cash | 622 | 240 | 934 | 605 |
Cost of Revenue | -76,599 | 146,138 | -4,067 | |
Free Cash Flow | -397,341 | -436,900 | -307,982 | -173,393 |
Cash | 265,452 | 104,641 | 181,101 | 34,915 |
Basic Shares | 508,635 | 399,900 | 389,234 | 383,179 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.20 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.35 |
2023-09-30 | -$0.19 |
